Showing results (671-680 of 928) with videos related to

Sort By:
Pageof 93
The Lancet. Diabetes & Endocrinology|September 29, 2025
Glucocorticoid-induced osteoporosis: novel concepts and clinical implicationsLorenz C Hofbauer, Juliet E Compston, Kenneth G Saag, et al.
The Lancet. Diabetes & Endocrinology|September 11, 2025
Strengthening non-communicable disease care in all-hazards emergenciesKiran Jobanputra, Sigiriya Aebischer Perone, Éimhín Ansbro, et al.
The Lancet. Diabetes & Endocrinology|June 22, 2025
Efficacy and safety of automated insulin delivery in children aged 2-6 years (LENNY): an open-label, multicentre, randomised, crossover trialTadej Battelino, Salla Kuusela, Ambika Shetty, et al.
The Lancet. Diabetes & Endocrinology|April 3, 2025
Roux-en-Y gastric bypass, adjustable gastric banding, or sleeve gastrectomy for severe obesity (By-Band-Sleeve): a multicentre, open label, three-group, randomised controlled trial
The Lancet. Diabetes & Endocrinology|March 27, 2025
Futility of plasmapheresis, insulin in normoglycaemic individuals, or heparin in the treatment of hypertriglyceridaemia-induced acute pancreatitisMajid M Syed-Abdul, Lili Tian, Robert A Hegele, et al.
The Lancet. Diabetes & Endocrinology|March 12, 2026
Trends in cause-specific mortality among people with and without diabetes in high-income settings: a multinational, population-based studyDianna J Magliano, Jedidiah I Morton, Lei Chen, et al.
The Lancet. Diabetes & Endocrinology|February 23, 2026
Efficacy and safety of relacorilant for the treatment of patients with Cushing's syndrome (GRACE): a multicentre, phase 3, double-blind, placebo-controlled, randomised-withdrawal studyRosario Pivonello, Giorgio Arnaldi, Richard J Auchus, et al.
The Lancet. Diabetes & Endocrinology|February 4, 2024
Air pollution exposure and cardiometabolic riskSanjay Rajagopalan, Robert D Brook, Pedro R V O Salerno, et al.
The Lancet. Diabetes & Endocrinology|February 1, 2024
A proposed clinical classification for pituitary neoplasms to guide therapy and prognosisKen K Y Ho, Maria Fleseriu, John Wass, et al.
The Lancet. Diabetes & Endocrinology|May 6, 2024
Use of melatonin supplements and risk of type 2 diabetes and cardiovascular diseases in the USA: insights from three prospective cohort studiesYanping Li, Tianyi Huang, Susan Redline, et al.
Pageof 93